Hims & Hers Health Inc (NYSE: HIMS)’s stock price has increased by 3.61 compared to its previous closing price of 7.47. However, the company has seen a 10.57% increase in its stock price over the last five trading sessions. The Motley Fool reported 2023-11-16 that Hims & Hers reported another strong quarter this month as its growth rate remains above 50%. The company raised its forecast for the year as well.

Is It Worth Investing in Hims & Hers Health Inc (NYSE: HIMS) Right Now?

while the 36-month beta value is 0.64.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price point forecasted by analysts for Hims & Hers Health Inc (HIMS) is $10.39, which is $2.65 above the current market price. The public float for HIMS is 135.77M, and currently, short sellers hold a 12.49% ratio of that floaft. The average trading volume of HIMS on November 21, 2023 was 2.40M shares.

HIMS’s Market Performance

HIMS’s stock has seen a 10.57% increase for the week, with a 29.00% rise in the past month and a 14.84% gain in the past quarter. The volatility ratio for the week is 4.53%, and the volatility levels for the past 30 days are at 5.29% for Hims & Hers Health Inc The simple moving average for the past 20 days is 17.59% for HIMS’s stock, with a -8.51% simple moving average for the past 200 days.

Analysts’ Opinion of HIMS

Many brokerage firms have already submitted their reports for HIMS stocks, with TD Cowen repeating the rating for HIMS by listing it as a “Outperform.” The predicted price for HIMS in the upcoming period, according to TD Cowen is $11 based on the research report published on July 28, 2023 of the current year 2023.

HIMS Trading at 21.15% from the 50-Day Moving Average

After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.28% of loss for the given period.

Volatility was left at 5.29%, however, over the last 30 days, the volatility rate increased by 4.53%, as shares surge +25.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.53% upper at present.

During the last 5 trading sessions, HIMS rose by +10.57%, which changed the moving average for the period of 200-days by -1.90% in comparison to the 20-day moving average, which settled at $6.66. In addition, Hims & Hers Health Inc saw 20.75% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HIMS starting from Baird Melissa, who sale 9,133 shares at the price of $7.09 back on Nov 08. After this action, Baird Melissa now owns 403,849 shares of Hims & Hers Health Inc, valued at $64,735 using the latest closing price.

Baird Melissa, the Chief Operating Officer of Hims & Hers Health Inc, sale 9,133 shares at $7.07 during a trade that took place back on Nov 07, which means that Baird Melissa is holding 403,849 shares at $64,539 based on the most recent closing price.

Stock Fundamentals for HIMS

Current profitability levels for the company are sitting at:

The net margin for Hims & Hers Health Inc stands at -12.46. The total capital return value is set at -20.84, while invested capital returns managed to touch -20.08. Equity return is now at value -11.16, with -8.96 for asset returns.

Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 1.70 points at debt to equity in total, while total debt to capital is 1.67. Total debt to assets is 1.45, with long-term debt to equity ratio resting at 1.17. Finally, the long-term debt to capital ratio is 1.15.

When we switch over and look at the enterprise to sales, we see a ratio of 1.78, with the company’s debt to enterprise value settled at 0.00. The receivables turnover for the company is 154.79 and the total asset turnover is 1.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.52.


In a nutshell, Hims & Hers Health Inc (HIMS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.